Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 -- Roivant today reported its financial results for the third quarter ended December 31, 2023, and provided a business update. Roivant...

Related Keywords

Japan ,London ,City Of ,United Kingdom ,Switzerland ,Matt Gline ,Stephanie Lee ,Exchange Commission ,Securities Exchange ,Pfizer ,National Prescription Audit ,Proteovant Sciences Inc ,Roivant Sciences Ltd ,Roivant Sciences ,Development Expenses ,Eczema Area ,Severity Index ,Peak Pruritus Numeric Rating Scale ,Quarter Ended December ,Proteovant Sciences ,Telavant Net ,Consolidated Statements ,Securities Act ,Securities Exchange Act ,Risk Factors ,Prescription Audit ,Markets ,